(NASDAQ:TCRT) ALAUNOS THERAPEUDICS INC. shares are climbing today in the pre-market up more than 31% on an astounding 36,000 trades and climbing. 

Shares are at $1.12 The company recently announced plans to present at an upcoming conference. The stock has significant pre-market volume with more than 9.751 million shares traded as of this post.

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq:TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research & Development will present at the upcoming Jefferies Healthcare Conference being held on June 8-10, 2022, in New York, NY.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.